Pancreatic Neuroendocrine Tumor：Factor of Surgery Influencing Survival

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

2 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-12-31

Study Completion Date

2016-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Investigator determined the factor of surgery associated with the survival of pancreatic neuroendocrine tumor.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The variables including clinical characteristics, surgical data and pathological findings are examined by univariate and multivariate analyses.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pancreatic Neuroendocrine Tumor

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

RETROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

pancreatectomy

Remove the pancreatic neuroendocrine tumor by surgery

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* The patients with pancreatic neuroendocrine tumor underwent pancreatectomy

Exclusion Criteria

* The patients with pancreatic neuroendocrine tumor did not undergo pancreatectomy

Minimum Eligible Age

10 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Qinchang Chen

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Shaowei Gao, Doctor

Role: STUDY_DIRECTOR

First Affiliated Hospital, Sun Yat-Sen University

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Qinchang Chen, Doctor

Role: CONTACT

[email protected]

18819430530

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SYSU 211

Identifier Type: -

Identifier Source: org_study_id